FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Meir Ohana

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Anatomy

Procedures

Physiology

Immune Tolerance

Co-author Network

Publications

TOP 3
Yaron Ilan; Meir Ohana; Orit Pappo; Maya Margalit; Gadi Lalazar; Dean Engelhardt; Elazar Rabbani; Arnon Nagler
Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity.
Dan Arbell; Raphael Udassin; Benjamin Z Koplewitz; Meir Ohana; Olga Genina; Mark Pines; Arnon Nagler
Prevention of esophageal strictures in a caustic burn model using halofuginone, an inhibitor of collagen type I synthesis.
Yaron Ilan; Maya Margalit; Meir Ohana; Israel Gotsman; Elazar Rabbani; Dean Engelhardt; Arnon Nagler
Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Meir Ohana (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Yaron Ilan; Meir Ohana; Orit Pappo; Maya Margalit; Gadi Lalazar; Dean Engelhardt; Elazar Rabbani; Arnon Nagler
Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity.
Transplantation 2007;83(4):458-67.
2005: Dan Arbell; Raphael Udassin; Benjamin Z Koplewitz; Meir Ohana; Olga Genina; Mark Pines; Arnon Nagler
Prevention of esophageal strictures in a caustic burn model using halofuginone, an inhibitor of collagen type I synthesis.
The Laryngoscope 2005;115(9):1632-5.
2005: Yaron Ilan; Maya Margalit; Meir Ohana; Israel Gotsman; Elazar Rabbani; Dean Engelhardt; Arnon Nagler
Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
Human immunology 2005;66(3):231-40.
2005: Maya Margalit; Yaron Ilan; Meir Ohana; Rifaat Safadi; Ruslana Alper; Yoav Sherman; Victoria Doviner; Elazar Rabbani; Dean Engelhardt; Arnon Nagler
Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.
Bone marrow transplantation 2005;35(2):191-7.
2004: Arnon Nagler; Meir Ohana; Oren Shibolet; M Y Shapira; Ruslana Alper; I Vlodavsky; Mark Pines; Yaron Ilan
Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone.
European journal of cancer (Oxford, England : 1990) 2004;40(9):1397-403.
2003: Arnon Nagler; Meir Ohana; Ruslana Alper; Victoria Doviner; Yoav Sherman; Elazar Rabbani; Dean Engelhardt; Yaron Ilan
Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model.
Bone marrow transplantation 2003;32(4):363-9.
2001: Mark Pines; A Domb; Meir Ohana; J Inbar; Olga Genina; Rosaly Alexiev; Arnon Nagler
Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone.
Biochemical pharmacology 2001;62(9):1221-7.
2000: Arnon Nagler; Ofer N Gofrit; Meir Ohana; Dov Pode; Olga Genina; Mark Pines
The effect of halofuginone, an inhibitor of collagen type i synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model.
The Journal of urology 2000;164(5):1776-80.
2000: Yaron Ilan; Israel Gotsman; Mark Pines; Roy Beinart; Michael Zeira; Meir Ohana; Elazar Rabbani; Dean Engelhardt; Arnon Nagler
Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model.
Blood 2000;95(11):3613-9.
2000: Arnon Nagler; Mark Pines; U Abadi; O Pappo; Michael Zeira; Elazar Rabbani; D Engelhardt; Meir Ohana; Namita Roy-Chowdhury; Jayanta Roy-Chowdhury; Yaron Ilan
Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.
Hepatology (Baltimore, Md.) 2000;31(3):641-8.
1999: Arnon Nagler; Olga Genina; Irena Lavelin; Meir Ohana; Mark Pines
Halofuginone, an inhibitor of collagen type I synthesis, prevents postoperative adhesion formation in the rat uterine horn model.
American journal of obstetrics and gynecology 1999;180(3 Pt 1):558-63.